1. Home
  2. KALA vs RAYA Comparison

KALA vs RAYA Comparison

Compare KALA & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • RAYA
  • Stock Information
  • Founded
  • KALA 2009
  • RAYA 2019
  • Country
  • KALA United States
  • RAYA China
  • Employees
  • KALA N/A
  • RAYA N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • KALA Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • KALA Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • KALA 5.1M
  • RAYA 4.3M
  • IPO Year
  • KALA 2017
  • RAYA 2022
  • Fundamental
  • Price
  • KALA $0.89
  • RAYA $3.61
  • Analyst Decision
  • KALA Buy
  • RAYA
  • Analyst Count
  • KALA 3
  • RAYA 0
  • Target Price
  • KALA $31.50
  • RAYA N/A
  • AVG Volume (30 Days)
  • KALA 1.6M
  • RAYA 22.3K
  • Earning Date
  • KALA 11-19-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • KALA N/A
  • RAYA N/A
  • EPS Growth
  • KALA N/A
  • RAYA N/A
  • EPS
  • KALA N/A
  • RAYA N/A
  • Revenue
  • KALA N/A
  • RAYA $30,300,360.00
  • Revenue This Year
  • KALA N/A
  • RAYA $20.95
  • Revenue Next Year
  • KALA N/A
  • RAYA N/A
  • P/E Ratio
  • KALA N/A
  • RAYA N/A
  • Revenue Growth
  • KALA N/A
  • RAYA 49.10
  • 52 Week Low
  • KALA $0.61
  • RAYA $3.13
  • 52 Week High
  • KALA $20.60
  • RAYA $736.99
  • Technical
  • Relative Strength Index (RSI)
  • KALA 39.51
  • RAYA 49.24
  • Support Level
  • KALA $0.61
  • RAYA $3.13
  • Resistance Level
  • KALA $0.70
  • RAYA $4.15
  • Average True Range (ATR)
  • KALA 0.09
  • RAYA 0.37
  • MACD
  • KALA 0.25
  • RAYA -0.03
  • Stochastic Oscillator
  • KALA 70.38
  • RAYA 72.92

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: